BIG
VIR icon

Brooklyn Investment Group’s Vir Biotechnology VIR Stock Holding History

Brooklyn Investment Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$152K Buy
+16,957
New +$135K ﹤0.01% 1757
2025
Q3 		– Sell
-9,583
Closed -$48.3K – 2621
2025
Q2 		$48.3K Buy
9,583
+9,474
+8,692% +$50.8K 0.01% 1350
2025
Q1 		$707 Buy
109
+108
+10,800% +$960 ﹤0.01% 2441
2024
Q4 		$8 Buy
+1
New +$8 ﹤0.01% 1931

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GP
GSK plc London $602M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Brooklyn Investment Group's VIR Position: Q1 2026 in Review

Brooklyn Investment Group opened a new position in Vir Biotechnology (VIR) in Q1 2026: 16,957 shares worth $152K. The stake represents ﹤0.01% of the portfolio and ranks #1757 among its holdings. This is a return to the name: Brooklyn Investment Group previously reported a position in VIR as recently as Q2 2025.

Brooklyn Investment Group first reported a position in VIR in Q4 2024 and has held it in 4 quarters since. 252 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Brooklyn Investment Group held 16,957 shares of Vir Biotechnology worth $152K as of Q1 2026.
  • Vir Biotechnology was a new Brooklyn Investment Group position in Q1 2026.
  • Vir Biotechnology made up ﹤0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1757 holding.
  • Brooklyn Investment Group first reported a position in Vir Biotechnology in Q4 2024 and has held it in 4 quarters since.
  • 252 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.